Ask the Experts: Psychiatry & Mental Health

Medscape's Ask the Experts allows you to ask members of a panel of leading experts for advice or information. You also have the opportunity to share your own views and insights by clicking the "Discuss this" link at the top of each response.

 

Ask the Experts

  • How Does TMS Work in Treating Refractory Depression? What is the pharmacologic mechanism of transcranial magnetic stimulation (TMS)?
  • How Can I Recognize Munchausen Syndrome by Proxy? When should I suspect Munchausen syndrome by proxy in a patient?
  • CME ADHD and Social Anxiety; Treatment During Pregnancy Stimulants work but exacerbate nail biting and other nervous habits; any suggestions? What treatments are safe during pregnancy?
  • Does Quetiapine Produce False-Positive Methadone Tests? Recent reports have alleged false-positive methadone blood tests attributed to quetiapine.
  • Are Duloxetine's Side Effects Dose Related? A patient with depression and fibromyalgia pain experiences sleepiness, fatigue, and dizziness after her dosage of duloxetine is increased to 120 mg. Is this because of the higher dosage?
  • How Can I Help the Family of a Convicted Pedophile? I am counseling a client whose husband was recently incarcerated for sexually abusing young girls. She has many questions about pedophilia. Can you give me some guidance?
  • Is It Safe to Use "Natural" Sleep Aids While Taking Antidepressants? Patients on antidepressants frequently have trouble sleeping, but should they use therapies such as melatonin or tryptophan to address the problem?
  • Insight and Schizophrenia What evidence-based treatment improves insight? In what phase of the illness is such intervention best? What undesirable clinical effects can insight have?
  • Smoking and Schizophrenia What evidence-based treatment improves insight? In what phase of the illness is such intervention best? What undesirable clinical effects can insight have?
  • State-of-the-art Treatment for Negative Symptoms of Schizophrenia What are primary negative symptoms? How can you treat them? What are secondary negative symptoms and what 3 factors are responsible for them? How can you treat secondary negative symptoms?
  • Lithium and Hair Loss What can you do if your patient's thyroid test results are normal, but she is losing her hair? Why? If that option does not work, what other choices do you have?
  • Prescribing an Afternoon 'Booster;' Patient Variations in Duration of Effect When are short-acting, afternoon doses of stimulant contraindicated in adults with ADHD?
  • Antipsychotics and Diabetes Which antipsychotics have the best metabolic profile? What should you do if your patient develops new-onset diabetes after taking antipsychotics? How can you best manage diabetes?
  • Antidepressant Withdrawal Mania as a Predictor of Bipolarity What is antidepressant withdrawal mania? What medications may be associated with this phenomenon and why? Does antidepressant withdrawal mania predict bipolarity?
  • The Effectiveness of ECT for Bipolar Disorder How effective is ECT for bipolar depression, depression with a switch into mania, refractory mania, and maintenance? For what 2 types of patients should it be considered a first-line treatment?
  • The Meaning of the Term "Bipolar Disorder" What differentiates bipolar from unipolar depression? What factors are relevant when considering antidepressants?
  • What Can I Do to Help Patients With Belonephobia (Fear of Needles)? I frequently encounter patients with severe belonephobia. Some actually refuse injections of pain medication after major surgery. Others faint just waiting in line for injections. What can be done?
  • Distinguishing Bipolar From Unipolar Depression How can you recognize the depressed patient who is at increased risk for development of bipolar disorder? Here are some practical tips.
  • Atypical Antipsychotics and Bipolar Disorder Are olanzapine, quetiapine, ziprasidone, aripiprazole, and risperidone mood stabilizers? For how long can these atypical antipsychotics prevent relapses? When are relapses most likely to occur?
  • Antidepressants in the Pipeline What drugs act as agonists at the neurokinin (NK) level? How are they useful? When might they be approved by the FDA?
 

Disclaimer
The information in this web site reflects the views of the authors only and not Medscape. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers should verify all information and data before treating patients or utilizing any therapies noted in this program.

 

Ask a Question

Ask a Question

Ask Medscape's Expert Panel Clinical Questions on the following topics:

 
 
Expert Panel
  • Lindsay DeVane, PharmDLindsay DeVane, PharmD, Professor and Vice Chair for Research, Department of Psychiatry, Medical University of South Carolina, Charleston
  • Mark A. Frye, MDMark A. Frye, MD, Associate Professor, Department of Psychiatry, University of Minnesota, Minneapolis; Director, UCLA Bipolar Program, Los Angeles, California
  • Martin T. Hoffman, MDMartin T. Hoffman, MD, Associate Professor of Clinical Pediatrics, University at Buffalo School of Medicine and Biomedical Science, Buffalo, New York; Attending Physician, General Pediatrics, Women and Children's Hospital, Buffalo, New York; Medical Director, Center for Children and Families, Buffalo, New York.
  • John Kane, MDJohn Kane, MD, Professor of Psychiatry, Neurology, and Neuroscience, Albert Einstein College of Medicine, Bronx, New York; Chairman, Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York
  • Stefan Leucht, MDStefan Leucht, MD, Assistant Professor, Technical University of Munich, Germany; Consultant, Department of Psychiatry, Klinikum rechts der Isar, Munich, Germany.
  • Michael J. Manos, PhDMichael J. Manos, PhD, Head, Section of Behavioral Medicine, Division of Pediatrics, The Cleveland Clinic, Cleveland, Ohio.
  • Raun D. Melmed, MDRaun D. Melmed, MD, Director, Melmed Center, Scottsdale, Arizona
  • John Newcomer, MDJohn Newcomer, MD, Professor of Psychiatry, Psychology and Medicine, Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri
  • Adelaide S. Robb, MDAdelaide S. Robb, MD, Associate Professor, George Washington University School of Medicine, Washington, DC; Medical Director, Inpatient Psychiatry, Children's National Medical Center, Washington, DC.
  • Craig B.H. Surman, MDCraig B.H. Surman, MD, Instructor in Psychiatry, Harvard Medical School; Scientific Coordinator, Adult ADHD Research Program, Massachusetts General Hospital, Cambridge, Massachusetts.
  • Michael E. Thase, MDMichael E. Thase, MD, Professor of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Chief, Division of Adult Academic Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.